{"title_page": "Complement 3 deficiency", "text_new": "{{Infobox medical condition (new)\n| name            = Complement 3 deficiency\n| synonyms        = \n| image           = \n| alt             = \n| caption         = \n| pronounce       = \n| field           = immunology\n| geneReviewsID   = \n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n'''Complement 3 deficiency''' is a genetic condition affecting [[complement component 3]] (C3). People can suffer from either primary or secondary C3 deficiency. Primary C3 deficiency refers to an inherited autosomal-recessive disorder that involves mutations in the gene for C3.<ref name=\":0\">{{Cite journal|last=Okura|first=Yuka|last2=Kobayashi|first2=Ichiro|last3=Yamada|first3=Masafumi|last4=Sasaki|first4=Satoshi|last5=Yamada|first5=Yutaka|last6=Kamioka|first6=Ichiro|last7=Kanai|first7=Rie|last8=Takahashi|first8=Yutaka|last9=Ariga|first9=Tadashi|date=2016|title=Clinical characteristics and genotype-phenotype correlations in C3 deficiency|journal=Journal of Allergy and Clinical Immunology|volume=137|issue=2|pages=640\u2013644.e1|doi=10.1016/j.jaci.2015.08.017|pmid=26435005|issn=0091-6749|doi-access=free}}</ref> Secondary C3 deficiency results from a lack of [[Complement factor I|factor I]] or [[factor H]],  two proteins that are key for the regulation of C3.<ref name=\":1\">{{Cite journal|last=Degn|first=S\u00f8ren E.|last2=Jensenius|first2=Jens C.|last3=Thiel|first3=Steffen|date=2011|title=Disease-Causing Mutations in Genes of the Complement System|journal=The American Journal of Human Genetics|volume=88|issue=6|pages=689\u2013705|doi=10.1016/j.ajhg.2011.05.011|pmid=21664996|pmc=3113252|issn=0002-9297}}</ref> Both primary and secondary C3 deficiency are characterized by low levels or absence of C3.<ref name=\":2\">{{Cite journal|last=Skattum|first=Lillemor|last2=van Deuren|first2=Marcel|last3=van der Poll|first3=Tom|last4=Truedsson|first4=Lennart|date=2011|title=Complement deficiency states and associated infections|journal=Molecular Immunology|volume=48|issue=14|pages=1643\u20131655|doi=10.1016/j.molimm.2011.05.001|pmid=21624663|issn=0161-5890}}</ref>\n\n== C3 Function ==\n\n[[Complement component 3]] (C3) is a protein involved in both the [[Innate immune system|innate]] and [[Adaptive immune system|adaptive]] immune response. C3 is one of over 30 complement proteins circulating in the blood.<ref name=\":2\" /> C3 circulates in an inactive form but can be activated in order to aid the immune system's response to a foreign invader.<ref name=\":3\">{{Cite journal|last=S. Reis|first=E.|last2=Falcao|first2=D. A.|last3=Isaac|first3=L.|date=2006|title=Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H|journal=Scandinavian Journal of Immunology|volume=63|issue=3|pages=155\u2013168|doi=10.1111/j.1365-3083.2006.01729.x|pmid=16499568|issn=0300-9475}}</ref> C3 is the most abundant complement component and is a particularly important complement component because there are three ways to activate the [[complement system]], but C3 plays a central role in all three of these pathways<ref name=\":0\" /> (see the pages for the [[Classical complement pathway|classical pathway]], [[Alternative complement pathway|alternative pathway]], and the [[lectin pathway]]). Each of these pathways involves the formation of a [[C3-convertase]], which will cleave C3 molecules into C3a and C3b fragments.<ref name=\":3\" /> This is important because an unregulated C3-convertase will cause a deficiency of intact C3 molecules by generating these fragments.<ref name=\":1\" />\n\nThe human gene for C3 is located on chromosome 19.<ref name=\":3\" /> In a healthy individual, C3 is secreted by hepatocytes (liver cells) as well as monocytes and macrophages, dendritic cells, polymorphonuclear leukocytes, fibroblasts, and endothelial cells. These cells will increase production of C3 in response to cytokine signaling (from [[Interleukin-1 family|IL-1]], [[Interleukin 6|IL-6]], [[Tumor necrosis factor alpha|TNF-alpha]], or [[interferon gamma]]) or in response to the presence of [[Lipopolysaccharide]] (LPS), which is expressed in the outer membrane of gram-negative bacteria.<ref name=\":3\" />\n\n== Cases of Complement 3 Deficiency ==\n\nAs of 2016, primary C3 deficiency had been observed in 37 individuals (from 29 families) around the world.<ref name=\":0\" />Patients with primary or secondary C3 deficiency generally displayed symptoms (i.e. suffered from infection) within the first 2 years of life.<ref name=\":0\" /><ref name=\":3\" />\n\nIn addition to studying C3 deficiency in diagnosed human patients, researchers have studied C3 deficiency in animals. C3 deficiency can be induced by injecting animals with cobra venom factor (CVF). CVF functions like an unregulated C3-convertase (because Factor I and factor H do not regulate it), cleaving most C3 molecules in the serum into C3a and C3b fragments (which depletes the amount of intact C3).<ref name=\":3\" />\n\n== Clinical Implications of Complement 3 Deficiency ==\n\nC3 deficiency makes an individual susceptible to severe, recurrent infections from [[Bacterial capsule|encapsulated bacteria.]]<ref name=\":3\" /><ref name=\"Parija\">{{cite book|author=Parija|url=https://books.google.com/books?id=HcgGLfxDJSQC&pg=PA125|title=Textbook of Microbiology & Immunology|date=2009-01-01|publisher=Elsevier India|isbn=978-81-312-2163-1|pages=125\u2013|accessdate=13 November 2010}}</ref><ref>{{Cite book|last=Gorbach, Sherwood L.|title=Infectious Diseases.|date=2003|publisher=LWW (PE)|others=Bartlett, John G., Blacklow, Neil R.|isbn=978-1-4698-7418-0|edition=3rd|location=Philadelphia|oclc=923530065}}</ref> These infections are more often caused by gram-negative bacteria (such as Neisseria meningitidis, Haemophilus influenzae, Klebsiella aerogenes, and Escherichia coli), but can also be caused by gram-positive bacteria (such as Streptococcus pneumoniae, Streptoccocus pyogenes, Staphylococcus aureus, and Streptococcus milleri).<ref name=\":3\" /><ref name=\":0\" />  Infections of the respiratory tract, such as pneumonia, have commonly been observed in C3 deficient patients.<ref name=\":3\" />\n\nIn some cases, primary and secondary C3 deficiency have been associated with the onset of rheumatic or renal (kidney) diseases, such as [[systemic lupus erythematosus]]<ref name=\"pmid11813855\">{{cite journal|vauthors=Matsuyama W, Nakagawa M, Takashima H, Muranaga F, Sano Y, Osame M|date=December 2001|title=Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters|journal=Intern. Med.|volume=40|issue=12|pages=1254\u20138|doi=10.2169/internalmedicine.40.1254|pmid=11813855|doi-access=free}}</ref>and [[membranoproliferative glomerulonephritis]].<ref name=\":2\" /> (Note that some studies have grouped rheumatic and renal diseases under the broader category of immune complex-mediated diseases.) There have been recorded cases of C3 deficient patients that suffer only from immune complex-mediated diseases and not severe, recurrent infections.<ref name=\":0\" />\n\nTreatment for C3 deficiency has generally involved the prescription of regular antibiotics intended to prevent infection.<ref name=\":3\" />\n\n\n\n<br />\n\n==References==\n{{reflist}}\n== External links ==\n{{Medical resources\n|  DiseasesDB      = 1869\n|  ICD10           = \n|  ICD9            =  \n|  ICDO            = \n|  OMIM            = 120700\n|  MedlinePlus     = \n|  eMedicineSubj   = \n|  eMedicineTopic  = \n|  MeshID          = \n|  GeneReviewsName = \n}}\n{{Lymphoid and complement immunodeficiency}}\n\n[[Category:Complement deficiency]]\n\n\n{{Immunology-stub}}\n", "text_old": "{{Infobox medical condition (new)\n| name            = Complement 3 deficiency\n| synonyms        = \n| image           = \n| alt             = \n| caption         = \n| pronounce       = \n| field           = immunology\n| geneReviewsID   = \n| symptoms        = \n| complications   = \n| onset           = \n| duration        = \n| types           = \n| causes          = \n| risks           = \n| diagnosis       = \n| differential    = \n| prevention      = \n| treatment       = \n| medication      = \n| prognosis       = \n| frequency       = \n| deaths          = \n}}\n'''Complement 3 deficiency''' is a genetic condition affecting [[complement component 3]] (C3). People can suffer from either primary or secondary C3 deficiency. Primary C3 deficiency refers to an inherited autosomal-recessive disorder that involves mutations in the gene for C3.<ref name=\":0\">{{Cite journal|last=Okura|first=Yuka|last2=Kobayashi|first2=Ichiro|last3=Yamada|first3=Masafumi|last4=Sasaki|first4=Satoshi|last5=Yamada|first5=Yutaka|last6=Kamioka|first6=Ichiro|last7=Kanai|first7=Rie|last8=Takahashi|first8=Yutaka|last9=Ariga|first9=Tadashi|date=2016|title=Clinical characteristics and genotype-phenotype correlations in C3 deficiency|journal=Journal of Allergy and Clinical Immunology|volume=137|issue=2|pages=640\u2013644.e1|doi=10.1016/j.jaci.2015.08.017|pmid=26435005|issn=0091-6749|doi-access=free}}</ref> Secondary C3 deficiency results from a lack of [[Complement factor I|factor I]] or [[factor H]],  two proteins that are key for the regulation of C3.<ref name=\":1\">{{Cite journal|last=Degn|first=S\u00f8ren\u00a0E.|last2=Jensenius|first2=Jens\u00a0C.|last3=Thiel|first3=Steffen|date=2011|title=Disease-Causing Mutations in Genes of the Complement System|journal=The American Journal of Human Genetics|volume=88|issue=6|pages=689\u2013705|doi=10.1016/j.ajhg.2011.05.011|pmid=21664996|pmc=3113252|issn=0002-9297}}</ref> Both primary and secondary C3 deficiency are characterized by low levels or absence of C3.<ref name=\":2\">{{Cite journal|last=Skattum|first=Lillemor|last2=van Deuren|first2=Marcel|last3=van der Poll|first3=Tom|last4=Truedsson|first4=Lennart|date=2011|title=Complement deficiency states and associated infections|journal=Molecular Immunology|volume=48|issue=14|pages=1643\u20131655|doi=10.1016/j.molimm.2011.05.001|pmid=21624663|issn=0161-5890}}</ref>\n\n== C3 Function ==\n\n[[Complement component 3]] (C3) is a protein involved in both the [[Innate immune system|innate]] and [[Adaptive immune system|adaptive]] immune response. C3 is one of over 30 complement proteins circulating in the blood.<ref name=\":2\" /> C3 circulates in an inactive form but can be activated in order to aid the immune system's response to a foreign invader.<ref name=\":3\">{{Cite journal|last=S. Reis|first=E.|last2=Falcao|first2=D. A.|last3=Isaac|first3=L.|date=2006|title=Clinical Aspects and Molecular Basis of Primary Deficiencies of Complement Component C3 and its Regulatory Proteins Factor I and Factor H|journal=Scandinavian Journal of Immunology|volume=63|issue=3|pages=155\u2013168|doi=10.1111/j.1365-3083.2006.01729.x|pmid=16499568|issn=0300-9475}}</ref> C3 is the most abundant complement component and is a particularly important complement component because there are three ways to activate the [[complement system]], but C3 plays a central role in all three of these pathways<ref name=\":0\" /> (see the pages for the [[Classical complement pathway|classical pathway]], [[Alternative complement pathway|alternative pathway]], and the [[lectin pathway]]). Each of these pathways involves the formation of a [[C3-convertase]], which will cleave C3 molecules into C3a and C3b fragments.<ref name=\":3\" /> This is important because an unregulated C3-convertase will cause a deficiency of intact C3 molecules by generating these fragments.<ref name=\":1\" />\n\nThe human gene for C3 is located on chromosome 19.<ref name=\":3\" /> In a healthy individual, C3 is secreted by hepatocytes (liver cells) as well as monocytes and macrophages, dendritic cells, polymorphonuclear leukocytes, fibroblasts, and endothelial cells. These cells will increase production of C3 in response to cytokine signaling (from [[Interleukin-1 family|IL-1]], [[Interleukin 6|IL-6]], [[Tumor necrosis factor alpha|TNF-alpha]], or [[interferon gamma]]) or in response to the presence of [[Lipopolysaccharide]] (LPS), which is expressed in the outer membrane of gram-negative bacteria.<ref name=\":3\" />\n\n== Cases of Complement 3 Deficiency ==\n\nAs of 2016, primary C3 deficiency had been observed in 37 individuals (from 29 families) around the world.<ref name=\":0\" />Patients with primary or secondary C3 deficiency generally displayed symptoms (i.e. suffered from infection) within the first 2 years of life.<ref name=\":0\" /><ref name=\":3\" />\n\nIn addition to studying C3 deficiency in diagnosed human patients, researchers have studied C3 deficiency in animals. C3 deficiency can be induced by injecting animals with cobra venom factor (CVF). CVF functions like an unregulated C3-convertase (because Factor I and factor H do not regulate it), cleaving most C3 molecules in the serum into C3a and C3b fragments (which depletes the amount of intact C3).<ref name=\":3\" />\n\n== Clinical Implications of Complement 3 Deficiency ==\n\nC3 deficiency makes an individual susceptible to severe, recurrent infections from [[Bacterial capsule|encapsulated bacteria.]]<ref name=\":3\" /><ref name=\"Parija\">{{cite book|author=Parija|url=https://books.google.com/books?id=HcgGLfxDJSQC&pg=PA125|title=Textbook of Microbiology & Immunology|date=2009-01-01|publisher=Elsevier India|isbn=978-81-312-2163-1|pages=125\u2013|accessdate=13 November 2010}}</ref><ref>{{Cite book|last=Gorbach, Sherwood L.|title=Infectious Diseases.|date=2003|publisher=LWW (PE)|others=Bartlett, John G., Blacklow, Neil R.|isbn=978-1-4698-7418-0|edition=3rd|location=Philadelphia|oclc=923530065}}</ref> These infections are more often caused by gram-negative bacteria (such as Neisseria meningitidis, Haemophilus influenzae, Klebsiella aerogenes, and Escherichia coli), but can also be caused by gram-positive bacteria (such as Streptococcus pneumoniae, Streptoccocus pyogenes, Staphylococcus aureus, and Streptococcus milleri).<ref name=\":3\" /><ref name=\":0\" />  Infections of the respiratory tract, such as pneumonia, have commonly been observed in C3 deficient patients.<ref name=\":3\" />\n\nIn some cases, primary and secondary C3 deficiency have been associated with the onset of rheumatic or renal (kidney) diseases, such as [[systemic lupus erythematosus]]<ref name=\"pmid11813855\">{{cite journal|vauthors=Matsuyama W, Nakagawa M, Takashima H, Muranaga F, Sano Y, Osame M|date=December 2001|title=Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters|journal=Intern. Med.|volume=40|issue=12|pages=1254\u20138|doi=10.2169/internalmedicine.40.1254|pmid=11813855|doi-access=free}}</ref>and [[membranoproliferative glomerulonephritis]].<ref name=\":2\" /> (Note that some studies have grouped rheumatic and renal diseases under the broader category of immune complex-mediated diseases.) There have been recorded cases of C3 deficient patients that suffer only from immune complex-mediated diseases and not severe, recurrent infections.<ref name=\":0\" />\n\nTreatment for C3 deficiency has generally involved the prescription of regular antibiotics intended to prevent infection.<ref name=\":3\" />\n\n\n\n<br />\n\n==References==\n{{reflist}}\n== External links ==\n{{Medical resources\n|  DiseasesDB      = 1869\n|  ICD10           = \n|  ICD9            =  \n|  ICDO            = \n|  OMIM            = 120700\n|  MedlinePlus     = \n|  eMedicineSubj   = \n|  eMedicineTopic  = \n|  MeshID          = \n|  GeneReviewsName = \n}}\n{{Lymphoid and complement immunodeficiency}}\n\n[[Category:Complement deficiency]]\n\n\n{{Immunology-stub}}\n", "name_user": "Trappist the monk", "label": "safe", "comment": "\u2192\u200etop:remove 'invisible' characters from cs1|2 template parameters; (NBSP)", "url_page": "//en.wikipedia.org/wiki/Complement_3_deficiency"}
